Biomarker Predictors of Clinical Efficacy of the Anti-IgE Biologic Omalizumab in Adults With Severe Asthma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
American Journal of Respiratory and Critical Care Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Biomarker Predictors of Clinical Efficacy of the Anti-IgE Biologic Omalizumab in Severe Asthma in Adults: Results of the SoMOSA Study
Am J Respir Crit Care Med 2024 Aug 01;210(3)288-297, R Djukanović, P Brinkman, J Kolmert, C Gomez, J Schofield, J Brandsma, A Shapanis, PJS Skipp, A Postle, C Wheelock, SE Dahlen, PJ Sterk, T Brown, DJ Jackson, A Mansur, I Pavord, M Patel, C Brightling, S Siddiqui, P Bradding, I Sabroe, D Saralaya, L Chishimba, J Porter, D Robinson, S Fowler, PH Howarth, L Little, T Oliver, K Hill, L Stanton, A Allen, D Ellis, G Griffiths, T Harrison, A Akenroye, J Lasky-Su, L Heaney, R Chaudhuri, R KurukulaaratchyFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.